最新的10Q里面提到：In connection with our process of exploring commercialization options for Symjepi in the U.S. market after the FDA approval in June 2017, we retainedan investment bank to assist us. We determined to engage in a process with the goal of maximizing the value of the asset. The process has been ongoing andas of the date of this Report on Form 10-Q, we are in active discussions with several potential partners regarding commercialization of the product. We havebegun building inventory in anticipation of a commercial launch.

个人认为公司会大概率的寻找合作伙伴，至于什么时候宣布合作伙伴，这是一个我无法解释的问题。

当前价值低估。